• MedX Health named Monaco-based Monaderm as a European sales agent for its SkinSecure SaaS platform targeting cosmetics and skin research.
• Deal expands regional commercialization of MedX’s non-invasive SIAscopy-based imaging technology that measures collagen, melanin, hemoglobin in a 30-second capture.
• SkinSecure links SIAscope devices to cloud workflows, enabling live, multi-site trial data access for contract research organizations and sponsors.
• SkinSecure launched in July 2026, secured initial clients, aims to add objective biological endpoints to cosmetic efficacy testing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MedX Health Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610050000BIZWIRE_USPR_____20261004_BW542395) on October 05, 2026, and is solely responsible for the information contained therein.